 Hakan Paydak
Concepts (239)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 25 | 2025 | 200 | 5.160 |
Why?
| | Defibrillators, Implantable | 10 | 2019 | 66 | 2.640 |
Why?
| | Catheter Ablation | 11 | 2025 | 125 | 2.170 |
Why?
| | Anti-Arrhythmia Agents | 8 | 2020 | 81 | 2.160 |
Why?
| | Electrocardiography | 11 | 2021 | 279 | 2.120 |
Why?
| | Arrhythmias, Cardiac | 5 | 2020 | 98 | 1.710 |
Why?
| | Tachycardia, Supraventricular | 3 | 2021 | 36 | 1.680 |
Why?
| | Hospitalization | 8 | 2025 | 739 | 1.460 |
Why?
| | Tachycardia | 3 | 2021 | 28 | 1.140 |
Why?
| | Amiodarone | 3 | 2017 | 23 | 1.030 |
Why?
| | Pacemaker, Artificial | 4 | 2019 | 42 | 0.910 |
Why?
| | Heart Rate | 4 | 2021 | 317 | 0.890 |
Why?
| | Vena Cava, Superior | 2 | 2015 | 22 | 0.820 |
Why?
| | Humans | 60 | 2025 | 52114 | 0.780 |
Why?
| | Anticoagulants | 5 | 2019 | 276 | 0.770 |
Why?
| | Tachycardia, Ventricular | 5 | 2020 | 45 | 0.720 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2020 | 37 | 0.660 |
Why?
| | Echocardiography, Transesophageal | 1 | 2020 | 60 | 0.650 |
Why?
| | Hospital Mortality | 5 | 2017 | 451 | 0.650 |
Why?
| | Middle Aged | 23 | 2025 | 13028 | 0.650 |
Why?
| | Male | 34 | 2025 | 26652 | 0.610 |
Why?
| | Warfarin | 3 | 2019 | 82 | 0.600 |
Why?
| | Metoprolol | 1 | 2019 | 13 | 0.600 |
Why?
| | Syncope | 2 | 2013 | 31 | 0.580 |
Why?
| | Bundle-Branch Block | 2 | 2012 | 19 | 0.570 |
Why?
| | Heparin | 2 | 2016 | 87 | 0.550 |
Why?
| | Treatment Outcome | 14 | 2022 | 5456 | 0.550 |
Why?
| | Heart Failure | 3 | 2019 | 565 | 0.540 |
Why?
| | Lung Diseases, Interstitial | 1 | 2017 | 26 | 0.520 |
Why?
| | Length of Stay | 4 | 2015 | 666 | 0.520 |
Why?
| | Hemothorax | 1 | 2016 | 4 | 0.520 |
Why?
| | Heart Conduction System | 2 | 2015 | 25 | 0.510 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2017 | 37 | 0.510 |
Why?
| | Cost of Illness | 2 | 2015 | 120 | 0.510 |
Why?
| | Prosthesis Implantation | 1 | 2016 | 48 | 0.500 |
Why?
| | Wolff-Parkinson-White Syndrome | 1 | 2016 | 7 | 0.490 |
Why?
| | Torsades de Pointes | 3 | 2014 | 15 | 0.490 |
Why?
| | Pneumonia | 1 | 2017 | 123 | 0.490 |
Why?
| | Propafenone | 1 | 2015 | 2 | 0.470 |
Why?
| | Tachycardia, Ectopic Atrial | 1 | 2015 | 3 | 0.470 |
Why?
| | Flecainide | 1 | 2015 | 4 | 0.470 |
Why?
| | Propofol | 1 | 2015 | 20 | 0.450 |
Why?
| | Accessory Atrioventricular Bundle | 1 | 2014 | 4 | 0.450 |
Why?
| | Hospital Costs | 1 | 2015 | 73 | 0.450 |
Why?
| | Heart Ventricles | 4 | 2015 | 264 | 0.450 |
Why?
| | Mucolipidoses | 1 | 2014 | 4 | 0.450 |
Why?
| | Female | 25 | 2025 | 28055 | 0.450 |
Why?
| | Postoperative Hemorrhage | 1 | 2015 | 54 | 0.450 |
Why?
| | Exercise Test | 1 | 2015 | 142 | 0.440 |
Why?
| | Electric Countershock | 4 | 2022 | 30 | 0.440 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2015 | 108 | 0.440 |
Why?
| | Hyponatremia | 1 | 2013 | 13 | 0.410 |
Why?
| | Takotsubo Cardiomyopathy | 1 | 2013 | 23 | 0.410 |
Why?
| | Patient Safety | 1 | 2014 | 102 | 0.410 |
Why?
| | Theophylline | 1 | 2013 | 18 | 0.400 |
Why?
| | Health Care Costs | 1 | 2014 | 174 | 0.400 |
Why?
| | Therapy, Computer-Assisted | 1 | 2013 | 31 | 0.400 |
Why?
| | Vascular Malformations | 1 | 2015 | 104 | 0.400 |
Why?
| | Seasons | 1 | 2013 | 92 | 0.390 |
Why?
| | Postoperative Complications | 3 | 2025 | 1071 | 0.380 |
Why?
| | Azygos Vein | 1 | 2012 | 9 | 0.380 |
Why?
| | Coronary Sinus | 1 | 2012 | 5 | 0.380 |
Why?
| | Electrodes, Implanted | 1 | 2012 | 32 | 0.380 |
Why?
| | Heart Block | 2 | 2009 | 26 | 0.380 |
Why?
| | Foreign-Body Migration | 1 | 2012 | 30 | 0.380 |
Why?
| | Superior Vena Cava Syndrome | 1 | 2012 | 10 | 0.380 |
Why?
| | Cardiac Resynchronization Therapy | 1 | 2012 | 21 | 0.370 |
Why?
| | Aged | 19 | 2025 | 10142 | 0.370 |
Why?
| | Vena Cava, Inferior | 1 | 2012 | 63 | 0.370 |
Why?
| | Catheters, Indwelling | 1 | 2012 | 56 | 0.370 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2012 | 34 | 0.370 |
Why?
| | Heart Diseases | 1 | 2014 | 220 | 0.370 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2012 | 34 | 0.360 |
Why?
| | Adult | 15 | 2022 | 14095 | 0.350 |
Why?
| | Sinoatrial Node | 1 | 2011 | 3 | 0.350 |
Why?
| | Catheterization, Central Venous | 1 | 2012 | 79 | 0.350 |
Why?
| | Obesity | 2 | 2025 | 1183 | 0.340 |
Why?
| | Incidence | 4 | 2019 | 1070 | 0.320 |
Why?
| | Retrospective Studies | 10 | 2023 | 6610 | 0.320 |
Why?
| | Head and Neck Neoplasms | 1 | 2013 | 285 | 0.320 |
Why?
| | Stroke | 3 | 2022 | 514 | 0.310 |
Why?
| | Diagnosis, Differential | 5 | 2019 | 1031 | 0.310 |
Why?
| | Haloperidol | 1 | 2009 | 46 | 0.300 |
Why?
| | Magnetic Resonance Imaging | 2 | 2017 | 1518 | 0.290 |
Why?
| | Aged, 80 and over | 7 | 2019 | 3382 | 0.270 |
Why?
| | Risk Factors | 8 | 2025 | 3922 | 0.270 |
Why?
| | Antipsychotic Agents | 1 | 2009 | 235 | 0.260 |
Why?
| | Multiple Myeloma | 3 | 2017 | 2999 | 0.260 |
Why?
| | Hypertension | 4 | 2019 | 565 | 0.240 |
Why?
| | Reproducibility of Results | 3 | 2015 | 1214 | 0.230 |
Why?
| | Survival Rate | 2 | 2019 | 945 | 0.220 |
Why?
| | Obesity, Morbid | 1 | 2025 | 89 | 0.220 |
Why?
| | Metformin | 1 | 2025 | 80 | 0.210 |
Why?
| | Time Factors | 7 | 2019 | 2970 | 0.210 |
Why?
| | Body Surface Potential Mapping | 1 | 2003 | 1 | 0.200 |
Why?
| | Pre-Excitation Syndromes | 1 | 2003 | 3 | 0.200 |
Why?
| | Hypoglycemic Agents | 1 | 2025 | 217 | 0.200 |
Why?
| | Adolescent | 6 | 2017 | 6681 | 0.200 |
Why?
| | Young Adult | 5 | 2017 | 4307 | 0.200 |
Why?
| | Databases, Factual | 6 | 2017 | 714 | 0.200 |
Why?
| | Arkansas | 3 | 2019 | 2016 | 0.190 |
Why?
| | Follow-Up Studies | 3 | 2019 | 2282 | 0.190 |
Why?
| | Vagus Nerve Stimulation | 1 | 2022 | 14 | 0.180 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 147 | 0.180 |
Why?
| | Blood Flow Velocity | 1 | 2001 | 95 | 0.180 |
Why?
| | Disease Management | 2 | 2020 | 185 | 0.180 |
Why?
| | Pericardial Effusion | 1 | 2001 | 39 | 0.180 |
Why?
| | Telemetry | 1 | 2021 | 27 | 0.180 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2001 | 70 | 0.170 |
Why?
| | Heart Arrest | 1 | 2022 | 135 | 0.160 |
Why?
| | Syndrome | 3 | 2015 | 247 | 0.160 |
Why?
| | Sick Sinus Syndrome | 1 | 2019 | 3 | 0.160 |
Why?
| | Hypoventilation | 1 | 2019 | 4 | 0.160 |
Why?
| | Recovery of Function | 1 | 2020 | 201 | 0.160 |
Why?
| | Sleep Apnea, Central | 1 | 2019 | 12 | 0.160 |
Why?
| | Hyperlipidemias | 1 | 2019 | 52 | 0.150 |
Why?
| | Diaphragm | 1 | 2019 | 33 | 0.150 |
Why?
| | Antithrombins | 1 | 2019 | 22 | 0.150 |
Why?
| | Artifacts | 1 | 2019 | 54 | 0.150 |
Why?
| | Echocardiography | 3 | 2017 | 415 | 0.150 |
Why?
| | Diabetes Complications | 1 | 2019 | 124 | 0.150 |
Why?
| | Heart Injuries | 1 | 2018 | 16 | 0.150 |
Why?
| | Atrial Flutter | 1 | 1998 | 9 | 0.150 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2025 | 562 | 0.150 |
Why?
| | Death, Sudden, Cardiac | 1 | 2019 | 59 | 0.150 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2018 | 28 | 0.140 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 321 | 0.140 |
Why?
| | United States | 5 | 2016 | 5168 | 0.140 |
Why?
| | Vascular System Injuries | 1 | 2018 | 38 | 0.140 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2019 | 111 | 0.140 |
Why?
| | Cardiotonic Agents | 1 | 2018 | 85 | 0.140 |
Why?
| | Cause of Death | 1 | 2019 | 162 | 0.140 |
Why?
| | Seizures | 2 | 2022 | 203 | 0.140 |
Why?
| | Ventricular Function, Left | 1 | 2019 | 177 | 0.140 |
Why?
| | Brain Ischemia | 1 | 2019 | 161 | 0.140 |
Why?
| | Comorbidity | 3 | 2014 | 628 | 0.140 |
Why?
| | Hemorrhage | 2 | 2019 | 222 | 0.130 |
Why?
| | Anti-Inflammatory Agents | 1 | 2018 | 166 | 0.130 |
Why?
| | Prednisone | 1 | 2017 | 102 | 0.130 |
Why?
| | Accidents, Traffic | 1 | 2017 | 90 | 0.130 |
Why?
| | Coronary Vessels | 1 | 2018 | 172 | 0.130 |
Why?
| | Clinical Trials as Topic | 3 | 2018 | 463 | 0.130 |
Why?
| | Ventricular Fibrillation | 2 | 2009 | 17 | 0.130 |
Why?
| | Administration, Oral | 2 | 2019 | 453 | 0.130 |
Why?
| | Heart Atria | 3 | 2012 | 64 | 0.130 |
Why?
| | Odds Ratio | 2 | 2015 | 564 | 0.120 |
Why?
| | Perioperative Period | 1 | 2016 | 21 | 0.120 |
Why?
| | Radiography, Thoracic | 1 | 2016 | 63 | 0.120 |
Why?
| | Sex Factors | 2 | 2016 | 731 | 0.120 |
Why?
| | Maternal Exposure | 1 | 2017 | 101 | 0.120 |
Why?
| | Voltage-Gated Sodium Channel Blockers | 1 | 2015 | 5 | 0.120 |
Why?
| | Ventricular Function | 1 | 2015 | 18 | 0.120 |
Why?
| | Age Factors | 2 | 2015 | 1125 | 0.120 |
Why?
| | Vitamin K | 1 | 2015 | 17 | 0.110 |
Why?
| | Glucocorticoids | 1 | 2017 | 236 | 0.110 |
Why?
| | Anesthetics, Intravenous | 1 | 2015 | 22 | 0.110 |
Why?
| | Insurance, Health | 1 | 2016 | 133 | 0.110 |
Why?
| | Thromboembolism | 1 | 2015 | 49 | 0.110 |
Why?
| | Forecasting | 1 | 2015 | 152 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2015 | 608 | 0.110 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 218 | 0.110 |
Why?
| | Fatal Outcome | 1 | 2015 | 192 | 0.110 |
Why?
| | Health Planning | 1 | 2014 | 13 | 0.110 |
Why?
| | Hematologic Neoplasms | 1 | 2015 | 100 | 0.110 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 267 | 0.110 |
Why?
| | Cardiomyopathies | 1 | 2015 | 121 | 0.110 |
Why?
| | Fibrinolytic Agents | 1 | 2015 | 131 | 0.110 |
Why?
| | Ultrasonography | 2 | 2012 | 420 | 0.100 |
Why?
| | Radiography | 1 | 2015 | 472 | 0.100 |
Why?
| | Methadone | 1 | 2014 | 183 | 0.100 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2013 | 45 | 0.100 |
Why?
| | Vasodilator Agents | 1 | 2013 | 93 | 0.100 |
Why?
| | Health Care Surveys | 1 | 2013 | 176 | 0.100 |
Why?
| | Bradycardia | 1 | 2012 | 38 | 0.090 |
Why?
| | Healthcare Disparities | 1 | 2016 | 296 | 0.090 |
Why?
| | Angioplasty | 1 | 2012 | 21 | 0.090 |
Why?
| | After-Hours Care | 1 | 2012 | 12 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 493 | 0.090 |
Why?
| | Prevalence | 1 | 2015 | 1013 | 0.090 |
Why?
| | Angiography | 1 | 2012 | 115 | 0.090 |
Why?
| | Mitral Valve | 1 | 2012 | 56 | 0.090 |
Why?
| | Phlebography | 1 | 2012 | 55 | 0.090 |
Why?
| | Device Removal | 1 | 2012 | 82 | 0.090 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2012 | 58 | 0.090 |
Why?
| | Patient Admission | 1 | 2012 | 80 | 0.090 |
Why?
| | Severity of Illness Index | 1 | 2015 | 1035 | 0.090 |
Why?
| | Disease Progression | 1 | 2014 | 866 | 0.090 |
Why?
| | Stem Cell Transplantation | 1 | 2012 | 186 | 0.090 |
Why?
| | Hospitals | 2 | 2023 | 180 | 0.090 |
Why?
| | Patient Discharge | 1 | 2013 | 322 | 0.090 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 871 | 0.080 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2015 | 597 | 0.080 |
Why?
| | Dextrocardia | 1 | 2009 | 4 | 0.080 |
Why?
| | Pregnancy | 1 | 2017 | 2658 | 0.080 |
Why?
| | Algorithms | 1 | 2013 | 663 | 0.080 |
Why?
| | Cross-Sectional Studies | 1 | 2014 | 1665 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2012 | 1148 | 0.060 |
Why?
| | Kidney Failure, Chronic | 1 | 2009 | 212 | 0.060 |
Why?
| | Cardiac Catheterization | 1 | 2009 | 241 | 0.060 |
Why?
| | Inpatients | 2 | 2022 | 206 | 0.060 |
Why?
| | Animals | 3 | 2025 | 13332 | 0.060 |
Why?
| | Magnetics | 1 | 2003 | 28 | 0.050 |
Why?
| | Vagus Nerve | 1 | 2022 | 23 | 0.050 |
Why?
| | Electrodes | 1 | 2022 | 34 | 0.050 |
Why?
| | False Negative Reactions | 1 | 2001 | 30 | 0.050 |
Why?
| | Echocardiography, Doppler | 1 | 2001 | 55 | 0.040 |
Why?
| | Coronary Artery Disease | 1 | 2025 | 317 | 0.040 |
Why?
| | Ambulances | 1 | 1999 | 8 | 0.040 |
Why?
| | Equipment Failure Analysis | 1 | 1999 | 44 | 0.040 |
Why?
| | Logistic Models | 2 | 2012 | 925 | 0.040 |
Why?
| | Arthralgia | 1 | 1999 | 44 | 0.040 |
Why?
| | Shoulder Joint | 1 | 1999 | 38 | 0.040 |
Why?
| | Drug Utilization | 1 | 2019 | 77 | 0.040 |
Why?
| | Motor Vehicles | 1 | 2017 | 14 | 0.030 |
Why?
| | Recurrence | 1 | 1998 | 680 | 0.030 |
Why?
| | Databases, Bibliographic | 1 | 2016 | 16 | 0.030 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2016 | 22 | 0.030 |
Why?
| | Medically Uninsured | 1 | 2016 | 46 | 0.030 |
Why?
| | Safety | 1 | 2015 | 80 | 0.030 |
Why?
| | Heart | 1 | 2017 | 360 | 0.030 |
Why?
| | Risk | 1 | 2015 | 312 | 0.030 |
Why?
| | Age Distribution | 1 | 2013 | 174 | 0.030 |
Why?
| | Systole | 1 | 2012 | 74 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 939 | 0.020 |
Why?
| | Transplantation, Autologous | 1 | 2012 | 480 | 0.020 |
Why?
| | Child | 1 | 2003 | 7147 | 0.020 |
Why?
| | Kidney Diseases | 1 | 2012 | 229 | 0.020 |
Why?
| | Opioid-Related Disorders | 1 | 2014 | 399 | 0.020 |
Why?
| | Situs Inversus | 1 | 2009 | 3 | 0.020 |
Why?
| | Prospective Studies | 1 | 2015 | 2424 | 0.020 |
Why?
| | Risk Assessment | 1 | 2012 | 1339 | 0.020 |
Why?
| | Kidney | 1 | 2012 | 713 | 0.020 |
Why?
| | Coronary Angiography | 1 | 2009 | 384 | 0.020 |
Why?
| | Pectoralis Muscles | 1 | 1999 | 6 | 0.010 |
Why?
| | Transportation of Patients | 1 | 1999 | 39 | 0.010 |
Why?
| | Physical Therapy Modalities | 1 | 1999 | 38 | 0.010 |
Why?
| | Range of Motion, Articular | 1 | 1999 | 108 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 1999 | 634 | 0.010 |
Why?
| | Software | 1 | 1999 | 280 | 0.010 |
Why?
|
|
Paydak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|